Skip to content
Screener

CONMED CNMD Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.1B-1.6%
Stryker logo
StrykerSYK
$2.66B+1.2%
Boston Scientific logo
Boston ScientificBSX
$2.47B+26.9%
Vericel logo
VericelVCEL
$1.91M+15.6%
OSI Systems logo
OSI SystemsOSIS
$130.76M-1.4%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$638.7M-27.3%

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.48B-8.8%
Enterprise value$2.46B-0.7%
P/E26.2×+11.5×
P/S1.1×-0.1×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemJune 30,2026December 31,2025
Total current liabilities455,399315,041
Long-term debt657,050834,230
Deferred income taxes84,58379,530
Other long-term liabilities61,88463,851
Total liabilities1,258,9161,292,652
Commitments and contingencies
Shareholders' equity:
Preferred stock, par value $0.01 per share;

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's other non-current liabilities?
CONMED (CNMD) reported other non-current liabilities of $61.88M in Q2 2026.
How has CONMED's other non-current liabilities changed year-over-year?
CONMED's other non-current liabilities decreased by 22.5% year-over-year, from $79.82M to $61.88M.
What is the long-term trend for CONMED's other non-current liabilities?
Over 5 years (2020 to 2025), CONMED's other non-current liabilities has grown at a 1.5% compound annual growth rate (CAGR), from $59.34M to $63.85M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about CONMED's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude